Sickle Cell Disease: Encouraging New Treatments

Sickle Cell Disease: Encouraging New Treatments

The U.S. Food and Drug Administration is working with patients and stakeholders including researchers and drug companies to help deliver new treatments to people living with sickle cell disease. Sickle cell disease is a chronic genetic disorder. It can cause pain, organ damage, and even stroke. Until recently, patients only had one FDA-approved drug treatment […]

Read More »